Hossein Ali Khazaei

Hossein Ali Khazaei

Auto-generated profile, based on publicly available information

Hossein Ali Khazaei

Clinical Immunology Research Center and Dept. of Immunology and hematology, Zahedan University of Medical Sciences, Zahedan-Iran

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2014 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
AAAsghar Aghamohammadi
Asghar Aghamohammadi
PMPayam Mohammadinejad
Payam Mohammadinejad
Hassan AbolhassaniHassan Abolhassani
Hassan Abolhassani
BMBabak Mirminachi
Babak Mirminachi
MMMasoud Movahedi
Masoud Movahedi
NRNima Rezaei
Nima Rezaei

1 November 2002 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
AAAsghar Aghamohammadi
Asghar Aghamohammadi
MMMosafa Moein
Mosafa Moein
AFAbolhasan Farhoudi
Abolhasan Farhoudi
ZPZahra Pourpak
Zahra Pourpak
NRNima Rezaei
Nima Rezaei
HKHosaynali Khazaei
Hosaynali Khazaei

1 October 2005 in European Journal of Epidemiology
Verified
Journal Article
Closed access
PDF file
HKHossein Ali Khazaei
Hossein Ali Khazaei
NRNima Rezaei
Nima Rezaei
GBGholam Reza Bagheri
Gholam Reza Bagheri
MDMohammad Ali Dankoub
Mohammad Ali Dankoub
KSKhalil Shahryari
Khalil Shahryari
MMMaryam Mahmoudi
Maryam Mahmoudi

25 September 2012 in International Archives of Allergy and Immunology
Verified
Journal Article
Closed access
HSHabib Soheili
Habib Soheili
Hassan AbolhassaniHassan Abolhassani
Hassan Abolhassani
NANarges Arandi
Narges Arandi
HKHossein Ali Khazaei
Hossein Ali Khazaei
SSShervin Shahinpour
Shervin Shahinpour
AAAsghar Aghamohammadi
Asghar Aghamohammadi
Background: Selective IgA deficiency (SIgAD) is the most common primary immunodeficiency disorder, which is characterized by significantly decreased serum levels of IgA. Abnormalities of CD4+CD25highforkhead box P3 (FoxP3)+ regulatory T cells (Treg) have been shown in association with autoimmune and inflammatory disorders. Methods: In order to evaluate the relationship between autoimmunity and Treg in SIgAD, we studied 26 IgA-deficient patients (aged 4–17 years) with serum IgA levels <7 mg/dl, 26 age- and sex-matched healthy controls and 26 age- and sex matched idiopathic thrombocytopenic purpura cases with normal immune system. Treg were determined by flow cytometry using Treg markers, including CD4, CD25 and FoxP3. Results: The mean percentage of CD4, CD25+FoxP3+ Treg from all CD4+ cells was 4.08 ± 0.86 in healthy controls, which was significantly higher than in SIgAD patients (2.93 ± 1.3; p = 0.003). We set a cutoff point (2.36%) for Treg, which was two standard deviations lower than the mean of normal controls. According to this cutoff point and in order to assess the role of Treg in clinical SIgAD manifestation, we classified patients into two groups: 16 patients in G1 with Treg <2.36% and 10 patients in G2 with Treg >2.36%. Autoimmunity was recorded in 9 patients (53.3%) of G1 and only 1 patient of G2, respectively (p = 0.034). Although a defect in class switching recombination was observed in 40% of the patients in G1, none of the G2 patients had such a defect (p = 0.028). Conclusion: This study showed decreased proportions of Treg in SIgAD patients, particularly in those with signs of chronic inflammation.

1 March 2017 in Immunotherapy
Verified
Journal Article
Closed access
SFShokrollah Farrokhi
Shokrollah Farrokhi
NANarjes Abbasirad
Narjes Abbasirad
AMAli Movahed
Ali Movahed
HKHossein Ali Khazaei
Hossein Ali Khazaei
MPMasoud Pishjoo
Masoud Pishjoo
NRNima Rezaei
Nima Rezaei
Toll-like receptors (TLRs), a family of pattern recognition receptors expressed on many cell types of innate immunity, recognize the pathogen-associated molecular patterns of microbes. The hygiene hypothesis suggests that a reduced microbial exposure in early childhood increases the susceptibility to allergic diseases due to deviation in development of the immune system. TLRs are key roles in the right and healthy direction of adaptive immunity with the induction of T-helper 2 toward Th1 immune responses and regulatory T cells. TLR ligand CpG-ODN-based immunomodulation is independent of allergen and it mainly affects innate immune system. While, CpG-oligodeoxynucleotide-based vaccination is allergen specific and induces adaptive immune system. The use of agonists of TLR9 in two distinct strategies of immunotherapy, immunomodulation and vaccination, could be presented as the curative method for the treatment of allergic diseases.

1 January 2015
Verified
Journal Article
Closed access
Hassan AbolhassaniHassan Abolhassani
Hassan Abolhassani
BGB Gharib
B Gharib
SSS Shahinpour
S Shahinpour
SMS N Masoom
S N Masoom
AHA Havaei
A Havaei
AAA Aghamohammadi
A Aghamohammadi